Award
Delivery Order #SPE2D326F6885
Pfizer Awarded Delivery Order for Critical Military Pharmaceutical
Buyer
Defense Logistics Agency
Award Amount
$1,499.40
Ceiling
$1,499.40
Awarded
March 02, 2026
Period of Performance
Mar 02, 2026 – Mar 03, 2026
Identifier
SPE2D326F6885
NAICS
325412
This award is a delivery order contract granted to Pfizer Inc., a leading global pharmaceutical company, renowned for supplying essential medical products including injectable medications. The contract procures Depo-Medrol 200 MG/5 ML vials, a vital corticosteroid medication used for various inflammatory conditions, underscoring the significance of maintaining critical pharmaceutical supplies for military health readiness. The scope of work encompasses the provision and delivery of the specified medication within a concise timeframe, supporting immediate operational needs. This delivery order is part of a broader, competitively awarded indefinite delivery vehicle contract held by Pfizer with the Department of Defense, which secures essential pharmaceuticals for military personnel over a long-term period. The award reflects a continuation of Pfizer's crucial partnership with the Defense Logistics Agency, facilitating timely access to indispensable medical resources. The contract duration is short-term, spanning just a couple of days, indicating a focused, urgent supply requirement fulfilled under the existing IDV framework.
Description
4571003029!DEPO-MEDROL 200 MG/5 ML VIAL 5ML